# Muscle Fatigue and Carbonic Anhydrase Inhibitors

> **NCT02758470** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 13 (actual)

## Conditions studied

- Hypoxia

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Methazolamide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02758470
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02758470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02758470, "Muscle Fatigue and Carbonic Anhydrase Inhibitors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02758470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*